Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Measurement of human and mouse interleukin-12.

Gately MK, Chizzonite R, Presky DH.

Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.16. doi: 10.1002/0471142735.im0616s15.

PMID:
18432807
2.

Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice.

French RA, VanHoy RW, Chizzonite R, Zachary JF, Dantzer R, Parnet P, Bluthé RM, Kelley KW.

J Neuroimmunol. 1999 Jan 1;93(1-2):194-202.

PMID:
10378883
3.

IL-1 receptor accessory protein is an essential component of the IL-1 receptor.

Cullinan EB, Kwee L, Nunes P, Shuster DJ, Ju G, McIntyre KW, Chizzonite RA, Labow MA.

J Immunol. 1998 Nov 15;161(10):5614-20.

4.

Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex.

Presky DH, Minetti LJ, Gillessen S, Wilkinson VL, Wu CY, Gubler U, Chizzonite R, Gately MK.

J Immunol. 1998 Mar 1;160(5):2174-9.

5.

Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.

van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, Chizzonite R, Corstens FH, van der Meer JW.

J Clin Invest. 1997 Dec 15;100(12):2970-6.

6.

Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.

Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, Aste-Amezaga M, Chizzonite R, Bazan JF, Kastelein RA.

Eur J Immunol. 1997 Nov;27(11):2787-92.

PMID:
9394800
7.

Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice.

Labow M, Shuster D, Zetterstrom M, Nunes P, Terry R, Cullinan EB, Bartfai T, Solorzano C, Moldawer LL, Chizzonite R, McIntyre KW.

J Immunol. 1997 Sep 1;159(5):2452-61.

PMID:
9278338
8.

Evidence for multiple sites of interaction between IL-12 and its receptor.

Presky DH, Minetti LJ, Gillessen S, Gubler U, Chizzonite R, Stern AS, Gately MK.

Ann N Y Acad Sci. 1996 Oct 31;795:390-3.

PMID:
8958964
9.

Interaction of phosphorylated FcepsilonRIgamma immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics.

Chen T, Repetto B, Chizzonite R, Pullar C, Burghardt C, Dharm E, Zhao Z, Carroll R, Nunes P, Basu M, Danho W, Visnick M, Kochan J, Waugh D, Gilfillan AM.

J Biol Chem. 1996 Oct 11;271(41):25308-15.

10.

Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse.

Welborn MB 3rd, Douglas WG, Abouhamze Z, Auffenburg T, Abouhamze AS, Baumhofer J, Seeger JM, Pruitt JH, Edwards PD, Chizzonite R, Martin D, Moldawer LL, Harward TR.

Shock. 1996 Sep;6(3):171-6.

PMID:
8885081
11.

Dual expression of p80 type I and p68 type II interleukin-I receptors on anterior pituitary cells synthesizing growth hormone.

French RA, Zachary JF, Dantzer R, Frawley LS, Chizzonite R, Parnet P, Kelley KW.

Endocrinology. 1996 Sep;137(9):4027-36. Review.

PMID:
8756580
12.

Biological function and distribution of human interleukin-12 receptor beta chain.

Wu CY, Warrier RR, Carvajal DM, Chua AO, Minetti LJ, Chizzonite R, Mongini PK, Stern AS, Gubler U, Presky DH, Gately MK.

Eur J Immunol. 1996 Feb;26(2):345-50.

PMID:
8617302
14.

IL12 receptors and receptor antagonists.

Presky DH, Gubler U, Chizzonite RA, Gately MK.

Res Immunol. 1995 Sep-Oct;146(7-8):439-45. Review. No abstract available.

PMID:
8839143
15.

Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response.

Oldenburg HS, Pruitt JH, Lazarus DD, Rogy MA, Chizzonite R, Lowry SF, Moldawer LL.

Cytokine. 1995 Aug;7(6):510-6.

PMID:
8580366
16.

Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex.

Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G.

J Biol Chem. 1995 Jun 9;270(23):13757-65.

17.

Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri).

Sarmiento UM, Riley JH, Knaack PA, Lipman JM, Becker JM, Gately MK, Chizzonite R, Anderson TD.

Lab Invest. 1994 Dec;71(6):862-73.

PMID:
7807968
18.

Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities.

Strassmann G, D'Alessandro F, Fong M, Nordan RP, Nickel P, Chizzonite R.

Int J Immunopharmacol. 1994 Nov;16(11):931-9.

PMID:
7868298
19.

Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction.

Ozmen L, Pericin M, Hakimi J, Chizzonite RA, Wysocka M, Trinchieri G, Gately M, Garotta G.

J Exp Med. 1994 Sep 1;180(3):907-15.

20.

Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor.

Hestdal K, Ruscetti FW, Chizzonite R, Ortiz M, Gooya JM, Longo DL, Keller JR.

Blood. 1994 Jul 1;84(1):125-32.

PMID:
8018912
21.

Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130.

Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK, et al.

J Immunol. 1994 Jul 1;153(1):128-36.

PMID:
7911493
22.

Characterization of anti-IL-1 alpha autoantibodies in the sera from healthy humans.

Satoh H, Chizzonite R, Ostrowski C, Ni-Wu G, Kim H, Fayer B, Mae N, Nadeau R, Liberato DJ.

Immunopharmacology. 1994 Mar-Apr;27(2):107-18.

PMID:
8014024
23.

Identification of sites on the human Fc epsilon RI alpha subunit which are involved in binding human and rat IgE.

Mallamaci MA, Chizzonite R, Griffin M, Nettleton M, Hakimi J, Tsien WH, Kochan JP.

J Biol Chem. 1993 Oct 15;268(29):22076-83.

24.

Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6.

Oldenburg HS, Rogy MA, Lazarus DD, Van Zee KJ, Keeler BP, Chizzonite RA, Lowry SF, Moldawer LL.

Eur J Immunol. 1993 Aug;23(8):1889-94.

PMID:
8344351
25.

Evidence that interleukin-1 mediates its effects on bone resorption via the 80 kilodalton interleukin-1 receptor.

Garrett IR, Guise TA, Bonewald LF, Chizzonite R, Mundy GR.

Calcif Tissue Int. 1993 Jun;52(6):438-41.

PMID:
8369991
26.

Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor.

Strassmann G, Masui Y, Chizzonite R, Fong M.

J Immunol. 1993 Mar 15;150(6):2341-5.

PMID:
8450216
27.

In vivo effect of interleukin-1 alpha on hematopoiesis: role of colony-stimulating factor receptor modulation.

Hestdal K, Jacobsen SE, Ruscetti FW, Dubois CM, Longo DL, Chizzonite R, Oppenheim JJ, Keller JR.

Blood. 1992 Nov 15;80(10):2486-94.

PMID:
1384785
28.

Interleukin 1: an important mediator of host resistance against Pneumocystis carinii.

Chen W, Havell EA, Moldawer LL, McIntyre KW, Chizzonite RA, Harmsen AG.

J Exp Med. 1992 Sep 1;176(3):713-8.

29.

Regulation of human cytolytic lymphocyte responses by interleukin-12.

Gately MK, Wolitzky AG, Quinn PM, Chizzonite R.

Cell Immunol. 1992 Aug;143(1):127-42.

PMID:
1352483
30.

Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes.

Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G.

J Clin Invest. 1992 Jul;90(1):262-6.

31.

IL-12 receptor. II. Distribution and regulation of receptor expression.

Desai BB, Quinn PM, Wolitzky AG, Mongini PK, Chizzonite R, Gately MK.

J Immunol. 1992 May 15;148(10):3125-32.

PMID:
1578139
32.

IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts.

Chizzonite R, Truitt T, Desai BB, Nunes P, Podlaski FJ, Stern AS, Gately MK.

J Immunol. 1992 May 15;148(10):3117-24.

PMID:
1578138
33.

Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI).

Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, Hanau D, de la Salle C.

J Exp Med. 1992 May 1;175(5):1285-90.

34.
35.

Molecular characterization of interleukin 12.

Podlaski FJ, Nanduri VB, Hulmes JD, Pan YC, Levin W, Danho W, Chizzonite R, Gately MK, Stern AS.

Arch Biochem Biophys. 1992 Apr;294(1):230-7.

PMID:
1347984
36.
37.

IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts.

Chizzonite R, Truitt T, Podlaski FJ, Wolitzky AG, Quinn PM, Nunes P, Stern AS, Gately MK.

J Immunol. 1991 Sep 1;147(5):1548-56.

PMID:
1715362
38.

Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys.

Hakimi J, Chizzonite R, Luke DR, Familletti PC, Bailon P, Kondas JA, Pilson RS, Lin P, Weber DV, Spence C, et al.

J Immunol. 1991 Aug 15;147(4):1352-9.

PMID:
1869828
39.

High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies.

Riske F, Hakimi J, Mallamaci M, Griffin M, Pilson B, Tobkes N, Lin P, Danho W, Kochan J, Chizzonite R.

J Biol Chem. 1991 Jun 15;266(17):11245-51.

40.
41.

Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance.

Neta R, Oppenheim JJ, Schreiber RD, Chizzonite R, Ledney GD, MacVittie TJ.

J Exp Med. 1991 May 1;173(5):1177-82.

43.

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.

McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Kilian PL.

J Exp Med. 1991 Apr 1;173(4):931-9.

44.

Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.

Gelin J, Moldawer LL, Lönnroth C, Sherry B, Chizzonite R, Lundholm K.

Cancer Res. 1991 Jan 1;51(1):415-21.

45.

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.

Stern AS, Podlaski FJ, Hulmes JD, Pan YC, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, et al.

Proc Natl Acad Sci U S A. 1990 Sep;87(17):6808-12.

46.
47.

Interleukin 1 receptor blockade attenuates the host inflammatory response.

Gershenwald JE, Fong YM, Fahey TJ 3rd, Calvano SE, Chizzonite R, Kilian PL, Lowry SF, Moldawer LL.

Proc Natl Acad Sci U S A. 1990 Jul;87(13):4966-70.

48.

Measurement of biologically active interleukin-1 by a soluble receptor binding assay.

Riske F, Chizzonite R, Nunes P, Stern AS.

Anal Biochem. 1990 Mar;185(2):206-12.

PMID:
2140248
49.

Hematopoietic activities of interleukin-1 alpha: in vitro and in vivo modulation by an anti-IL-1 receptor antibody.

Benjamin WR, Chizzonite RA, Tare NS, Plocinski JM, Kaffka KL, McIntyre KW, Faherty DA, Kilian PL.

Prog Clin Biol Res. 1990;349:355-63. No abstract available.

PMID:
2144644
50.

Characterization of mouse IL-1 receptors: evidence for IL-1 receptor heterogeneity.

Kilian PL, Stern AS, Gubler U, Chizzonite RA.

Prog Clin Biol Res. 1990;349:251-7. Review. No abstract available.

PMID:
2144638

Supplemental Content

Loading ...
Support Center